SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported) September 24, 1996


                               ENROTEK CORPORATION
             (Exact name of registrant as specified in its charter)

                                     Nevada
                 (State or other jurisdiction of incorporation)


               0-20934                                               88-0224414
(Commission File Number)                       (IRS Employer Identification No.)


1557 Bloor Street W., Toronto, Ontario, Canada                    M6P 1A5
(Address of principal executive offices)                       (Zip Code)


Registrant's telephone number, including area code           (416) 516-3720
                                                               --------------









































Item 5.  Other Events.


         By order signed October 9, 1996, the Registrant  obtained a preliminary
injunction in the Second Judicial District Court of Nevada Washoe County,  (Case
No.  CV96-05260)   against  its  former  president,   John  Leo  Lawson  Banach,
("Defendant").  The  following  is an excerpt of the  judge's  ruling  made as a
result of the September 24, 1996 hearing:

                  1.       Defendant is enjoined from calling any special 
         shareholders meetings of
         Plaintiff Enrotek Corporation until after a trial on the merits.

                  2. Defendant's actions taken at the September 16, 1996 special
         meeting of  shareholders of Enrotek  Corporation  shall be enjoined and
         have no force and effect until after a trial on the merits.

                  3.       Defendant is ordered to tender all stock associated
         with the Mems Martin
         agreement presently held by Enrotek Capital to the court on or before 
         Friday, October 4,
         1996, at 2:30 p.m.  Plaintiffs will prepare a receipt and 
         acknowledgement of the stock
         certificates.  Thereafter, Dr. Karim will be given the stock
         certificates at issue.

                  4.   Defendant  is  enjoined   from   incurring  any  debt  or
         transacting any business on behalf of Plaintiff Enrotek  Corporation or
         holding himself out as an officer or director of said corporation.

                  5.       Plaintiffs may continue to conduct the normal day to 
         day business
         operations of Enrotek Corporation.

                  6. All other Plaintiff  Corporation stock held by Defendant in
         his various privately owned corporations, including but not limited to,
         Mark Lawson Hughes,  Inc.,  Eurotrust 361143 Alberta Ltd., Mark Lawson,
         Inc.,  Enrotek  Capital,  Maria Banach  Foundation,  Alberta Ltd.,  and
         Alberta  Overseas  Private shall be retained by Defendant but cannot be
         sold,  transferred,  voted,  encumbered,  conveyed,  or  altered in any
         respect until after a trial on the merits. Specifically,  the shares in
         dispute by and between  the parties are 2.5 million  shares held in the
         above  referenced  businesses  privately  held  or  controlled  by  the
         Defendant.  Defendant also owns approximately 900,000 shares or Enrotek
         Corporation stock which are not the subject of this order, these shares
         of stock may be  encumbered,  sold, or conveyed as the Defendant  deems
         necessary.

                  7.       Defendant testified Plaintiff Corporation has no
          value and is merely a
         development company with a working board.

                  The  parties  agree the  primary  asset of  Plaintiff  Enrotek
                  Corporation is the Mems Martin land located in Portugal.

         The Registrant will seek at trial to cancel the 2.5 million shares held
by Banach controlled corporations.
         As a result of the above order and the conversion of preferred stock  
Dr. Karim owns


                                                         2





7,446,742 shares of common stock, or 61.1% of the 12,882,603 outstanding shares.
  Dr. Karim
is also a director of the Company.



                                                         3




                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.

Dated:            October 17, 1996                           ENROTEK CORPORATION


                                                  By:      /s/ Jaroslaw Shudrack
                                                      Name:    Jaroslaw Shudrack
                                                                       President